168 related articles for article (PubMed ID: 20677538)
21. [The revival of thalidomide: an old drug with new indications].
Laffitte E
Rev Prat; 2006 Nov; 56(18):1977-83. PubMed ID: 17274497
[TBL] [Abstract][Full Text] [Related]
22. [Should thalidomide be rehabilitated?].
Belaube P; Garcin G; Marchand JP; Privat Y
Sem Hop; 1983 Dec; 59(45):3101-4. PubMed ID: 6320398
[TBL] [Abstract][Full Text] [Related]
23. [Thalidomide: new indications for an old drug].
Laffitte E
Rev Med Suisse; 2005 Apr; 1(16):1074, 1077-80. PubMed ID: 15934472
[TBL] [Abstract][Full Text] [Related]
24. A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders.
Millrine D; Kishimoto T
Trends Mol Med; 2017 Apr; 23(4):348-361. PubMed ID: 28285807
[TBL] [Abstract][Full Text] [Related]
25. [Role of thalidomide in the treatment of multiple myeloma].
Mikala G; Jákó J; Vályi-Nagy I
Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
[TBL] [Abstract][Full Text] [Related]
26. Lenalidomide in the treatment of multiple myeloma: a review.
Armoiry X; Aulagner G; Facon T
J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408
[TBL] [Abstract][Full Text] [Related]
27. [Thalidomide: new uses for an old drug].
Wu KL; Sonneveld P
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
[TBL] [Abstract][Full Text] [Related]
28. Thalidomide: new preparation. For well-defined indications.
Prescrire Int; 1998 Oct; 7(37):131-4. PubMed ID: 10848043
[TBL] [Abstract][Full Text] [Related]
29. Thalidomide and its dermatologic uses.
Paghdal KV; Schwartz R
Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
[TBL] [Abstract][Full Text] [Related]
30. Lenalidomide in multiple myeloma.
Richardson PG; Mitsiades C; Hideshima T; Anderson KC
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1165-73. PubMed ID: 16925483
[TBL] [Abstract][Full Text] [Related]
31. The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes.
Melchert M; Kale V; List A
Curr Opin Hematol; 2007 Mar; 14(2):123-9. PubMed ID: 17255789
[TBL] [Abstract][Full Text] [Related]
32. Kellersberger Memorial Lecture 1979: immunosuppressive/anti-inflammatory thalidomide analogues.
Hastings RC
Ethiop Med J; 1980 Apr; 18(2):65-71. PubMed ID: 7418703
[No Abstract] [Full Text] [Related]
33. Thalidomide and lenalidomide in multiple myeloma.
Mazumder A; Jagannath S
Best Pract Res Clin Haematol; 2006; 19(4):769-80. PubMed ID: 16997182
[TBL] [Abstract][Full Text] [Related]
34. Thalidomide: a novel template for anticancer drugs.
Stirling D
Semin Oncol; 2001 Dec; 28(6):602-6. PubMed ID: 11740817
[TBL] [Abstract][Full Text] [Related]
35. Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomide.
Richardson P
Semin Hematol; 2005 Oct; 42(4 Suppl 4):S9-15. PubMed ID: 16344100
[TBL] [Abstract][Full Text] [Related]
36. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide.
Vetrichevvel TP; Pise GA; Thappa DM
Lepr Rev; 2008 Jun; 79(2):193-5. PubMed ID: 18711941
[TBL] [Abstract][Full Text] [Related]
37. [Current therapeutic indications of thalidomide and lenalidomide].
Ordi-Ros J; Cosiglio FJ
Med Clin (Barc); 2014 Apr; 142(8):360-4. PubMed ID: 23830554
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of erythema nodosum leprosum using thalidomide].
Sheskin J
Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
[No Abstract] [Full Text] [Related]
39. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?].
Sheskin J; Mückter H; Frankus E
Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166
[No Abstract] [Full Text] [Related]
40. Potential novel uses of thalidomide: focus on palliative care.
Peuckmann V; Fisch M; Bruera E
Drugs; 2000 Aug; 60(2):273-92. PubMed ID: 10983733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]